Literature DB >> 21684461

Enteral stents for malignant gastric outlet obstruction.

Bryan Brimhall1, Douglas G Adler.   

Abstract

Malignant gastric outlet obstruction (GOO) is a commonly encountered entity, defined as the inability of the stomach to empty because of mechanical obstruction at the level of either the stomach or the proximal small bowel. In this article, current literature on GOO is reviewed with a focus on enteral stents to include symptoms and diagnosis, stent and nonstent treatment, types of enteral stents, indications and contraindications to stent placement, and technical and clinical success rates. In comparison with gastrojejunostomy, enteral stent placement is better suited for patients with a shorter life expectancy and/or those who are poor surgical candidates.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21684461     DOI: 10.1016/j.giec.2011.04.002

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  10 in total

Review 1.  Surgical palliation of gastric outlet obstruction in advanced malignancy.

Authors:  Brittany A Potz; Thomas J Miner
Journal:  World J Gastrointest Surg       Date:  2016-08-27

2.  Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer.

Authors:  Sang Myung Woo; Dong Hwan Kim; Woo Jin Lee; Kyung Woo Park; Sang-Jae Park; Sung-Sik Han; Tae Hyun Kim; Young Hwan Koh; Hyun Bum Kim; Eun Kyung Hong
Journal:  Surg Endosc       Date:  2013-01-04       Impact factor: 4.584

3.  Palliative gastrojejunostomy versus endoscopic stent placement for gastric outlet obstruction in patients with unresectable gastric cancer: a propensity score-matched analysis.

Authors:  Seung Hyeon Jang; Hyuk Lee; Byung-Hoon Min; Su Mi Kim; Hye Seung Kim; Keumhee C Carriere; Yang Won Min; Jun Haeng Lee; Jae J Kim
Journal:  Surg Endosc       Date:  2017-03-09       Impact factor: 4.584

4.  Impact of Carcinomatosis on Clinical Outcomes after Self-Expandable Metallic Stent Placement for Malignant Gastric Outlet Obstruction.

Authors:  Ji Eun Lee; Keol Lee; Yun Soo Hong; Eun Ran Kim; Hyuk Lee; Byung-Hoon Min
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

5.  Enteral stenting for gastric outlet obstruction and afferent limb syndrome following pancreaticoduodenectomy.

Authors:  Wilson T Kwong; Syed M Fehmi; Andrew M Lowy; Thomas J Savides
Journal:  Ann Gastroenterol       Date:  2014

6.  Covered metallic stents with an anti-migration design vs. uncovered stents for the palliation of malignant gastric outlet obstruction: a multicenter, randomized trial.

Authors:  Hyuk Lee; Byung-Hoon Min; Jeong Hoon Lee; Cheol Min Shin; Younjoo Kim; Hyunsoo Chung; Sang Hyub Lee
Journal:  Am J Gastroenterol       Date:  2015-09-15       Impact factor: 10.864

Review 7.  Gastric Outlet Obstruction: Current Status and Future Directions.

Authors:  Ioannis S Papanikolaou; Peter D Siersema
Journal:  Gut Liver       Date:  2022-03-22       Impact factor: 4.321

Review 8.  Malignant gastric outlet obstruction: Which is the best therapeutic option?

Authors:  Edoardo Troncone; Alessandro Fugazza; Annalisa Cappello; Giovanna Del Vecchio Blanco; Giovanni Monteleone; Alessandro Repici; Anthony Yuen Bun Teoh; Andrea Anderloni
Journal:  World J Gastroenterol       Date:  2020-04-28       Impact factor: 5.742

9.  Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer.

Authors:  Yoon Suk Jung; Dong-Hoe Koo; Jeong-Yoon Yang; Hee-Young Lee; Jung-Hwan Park; Jung Ho Park
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

10.  Self-expandable metal stent of esophagogastric junction versus pyloric area obstruction in advanced gastric cancer patients: Retrospective, comparative, single-center study.

Authors:  Deok Yeong Kim; Hee Seok Moon; In Sun Kwon; Jae Ho Park; Ju Seok Kim; Sun Hyung Kang; Eaum Seok Lee; Seok Hyun Kim; Byung Seok Lee; Jae Kyu Sung; Hyun Yong Jeong
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.